Director of Research
In the Ley Group, we specialise in developing new synthesis methods and applying them to the construction of biologically important molecules. Over the years we have completed the total synthesis of many natural products, including: spongistatin 1 (anti-mitotic agent); rapamycin (immunosuppressant); thapsigargin (SERCA pumps inhibitor); azadirachtin (insect antifeedant); and bengazole A (fungicide). In addition to our research on natural product synthesis, we also pioneered flow chemistry and machine assisted synthesis.
For more detailed research information and our publication list, please see our legacy group website.
Completed Natural Products

Publications
Editorial - Flow Chemistry and Catalysis
Catalysis Science & Technology
(2016)
6
4676
(doi: 10.1039/c6cy90064j)
Correction: Controlled generation and use of CO in flow
Reaction Chemistry & Engineering
(2016)
1
340
(doi: 10.1039/c6re90010k)
Welcome to Reaction Chemistry & Engineering
Reaction Chemistry & Engineering
(2016)
1
8
(doi: 10.1039/c6re90001a)
Continuous-Flow Synthesis of 2 H -Azirines and Their Diastereoselective Transformation to Aziridines
Synlett
(2015)
27
159
(doi: 10.1055/s-0035-1560391)
Controlled Flow Precipitation as a Valuable Tool for Synthesis
Organic Process Research & Development
(2015)
20
371
(doi: 10.1021/acs.oprd.5b00331)
Synthesis of 1,3,6-Trisubstituted Azulenes
Journal of Organic Chemistry
(2015)
80
11513
(doi: 10.1021/acs.joc.5b02271)
A Novel Internet-Based Reaction Monitoring, Control and Autonomous Self-Optimization Platform for Chemical Synthesis
Organic Process Research & Development
(2015)
20
386
(doi: 10.1021/acs.oprd.5b00313)
Batch and Flow Synthesis of Pyrrolo[1,2-a]-quinolines via an Allene-Based Reaction Cascade
Journal of Organic Chemistry
(2015)
80
10806
(doi: 10.1021/acs.joc.5b01982)
Synthesis of a Precursor to Sacubitril Using Enabling Technologies.
Org Lett
(2015)
17
5436
(doi: 10.1021/acs.orglett.5b02806)
Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors (vol 101, pg 573, 2015)
European Journal of Medicinal Chemistry
(2015)
103
223
(doi: 10.1016/j.ejmech.2015.08.050)
- ‹ previous
- Page 11